QIAGEN

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell QIAGEN and other ETFs, options, and stocks.

About QGEN

QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials.

CEO

Thierry Bernard

CEOThierry Bernard

Employees

5,765

Employees5,765

Headquarters

Venlo, Limburg

HeadquartersVenlo, Limburg

Founded

1996

Founded1996

Employees

5,765

Employees5,765

QGEN Key Statistics

Market cap

10.30B

Market cap10.30B

Price-Earnings ratio

27.83

Price-Earnings ratio27.83

Dividend yield

0.53%

Dividend yield0.53%

Average volume

1.70M

Average volume1.70M

High today

$47.71

High today$47.71

Low today

$47.22

Low today$47.22

Open price

$47.27

Open price$47.27

Volume

891.13K

Volume891.13K

52 Week high

$51.88

52 Week high$51.88

52 Week low

$37.63

52 Week low$37.63

QGEN News

TipRanks 2d

Qiagen N.V. Announces Voting Rights Notification by AFM

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...

Simply Wall St 5d

Qiagen's Strong Earnings Are Of Good Quality

Qiagen N.V.'s ( ) earnings announcement last week was disappointing for investors, despite the decent profit numbers. Our analysis says that investors should be...

TipRanks 5d

Qiagen announces FDA clearance of QIAstat-Dx Rise

Qiagen (QGEN) announced the launch of QIAstat-Dx Rise – a version of the QIAstat-Dx automated syndromic testing system that offers throughput. The new system, w...

Analyst ratings

52%

of 25 ratings

Buy

48%

Hold

52%

Sell

People also own

Based on the portfolios of people who own QGEN. This list is generated using Robinhood data, and it’s not a recommendation.